Buying This Hidden Software Stock Might Just Give You Massive Exposure to the Anthropic IPO

Zoom's $51 million Anthropic investment was carried at $3.13 billion last quarter and could be worth roughly $7 billion if Anthropic completes an expected late-October or early-November IPO at a $2 trillion-plus valuation. Zoom's core business is stable-to-growing, with enterprise-suite revenue up 8%, remaining performance obligations up 14% to $4.5 billion, a 25% GAAP operating margin, and $1.9 billion of trailing-12-month free cash flow. After deducting estimated investments of $7.5 billion and $7.2 billion of cash from its $27 billion market capitalization, the article estimates a $12.3 billion enterprise value, or just under 10x $1.2 billion of EBIT; shares outstanding are also down 6% from their peak due to repurchases.

Analysis

The apparent sum-of-the-parts discount in ZM is real only if the Anthropic carrying value is monetizable near a prospective public-market valuation. That assumption deserves a large haircut: private-round marks can embed preferential terms, while an IPO typically introduces lockups, share-sale restrictions and a material gap between headline valuation and proceeds available to a minority financial investor. The near-term equity reaction should therefore be driven more by verified IPO filings and disclosure of Zoom's fully diluted ownership than by valuation headlines.

The core underwriting case is that enterprise products convert a stable installed base into higher ARPU and reduce the market's view of Zoom as a shrinking single-product asset. The key sensitivity over the next 1-3 quarters is whether enterprise expansion translates into sustained total revenue acceleration without sales-and-marketing reinvestment eroding operating leverage. If growth remains mid-single-digit while AI features are largely bundled rather than monetized, the stock may retain a low multiple despite its net-cash balance sheet and buyback capacity.

A second-order positive is capital allocation: a realizable gain on Anthropic could give ZM capacity for a substantially larger repurchase authorization, potentially creating a self-reinforcing reduction in share count at a depressed ex-investment valuation. Conversely, management may deploy the windfall into AI or contact-center acquisitions at elevated multiples, replacing a clean catalyst with integration risk. The contrarian view is that ZM is not a pure Anthropic proxy; investors buying solely for IPO exposure may sell once the IPO catalyst passes, particularly if the stake remains locked up.

The thesis is falsified by a lower-than-expected disclosed ownership stake, an IPO delay, restrictive monetization terms, or enterprise revenue growth failing to improve over two consecutive reports. Watch repurchase pace, RPO conversion, enterprise customer expansion, and any change in the fair-value methodology for strategic investments.

Key Decisions for Investors

• Initiate a modest long ZM only after an independently verifiable Anthropic filing or Zoom disclosure establishes fully diluted ownership and lockup terms; size as a 6-12 month SOTP/capital-return trade, not a pre-IPO event arb. Target requires a meaningful discount to a conservatively haircutted stake value; exit if enterprise growth decelerates or buybacks do not accelerate.
• Structure defined-risk upside with ZM 6-9 month call spreads rather than outright shares ahead of IPO-related headlines. This captures a rerating from confirmation while limiting loss if the IPO timetable, valuation, or liquidity assumptions prove promotional; avoid naked short-dated calls because timing is uncertain.
• For a cleaner relative-value expression, long ZM / short a basket of mature collaboration-software peers with weaker net-cash and strategic-asset optionality only after confirming comparable revenue-growth trends. Reassess at the next two earnings prints; close the pair if ZM's enterprise growth does not outperform or if peers show superior AI monetization.
• Set an alert for a material increase in repurchase authorization or tender activity following any Anthropic liquidity event. A demonstrated return of proceeds to shareholders is more investable than a mark-to-model gain; absence of such action shifts the thesis from catalyst-driven to value-trap risk.